Mesothelin overexpression in pancreatic cancer cells leads to the constitutive activation of NF-κB, thereby increasing the production of IL-6 and enhanced tumor cell proliferation and survival via auto/paracrine IL-6/sIL-6R trans-signaling. Here, MSLN is linked to familial pancreatic carcinoma.